Genelux GNLX
NASDAQ GNLX
$1.98 -0.09 (-4.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genelux (GNLX) Invested Capital (2022 - 2023)

Updated

Genelux's Invested Capital came in at $19.51 million for Q4 2023, compared with -$20.38 million a year earlier and down 18.9% from the prior quarter.

Analysis

Genelux (GNLX) Invested Capital (2022 - 2023) Analysis & Trends

  • Going back by year, Invested Capital was -$20.38 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 126.18 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 64.89 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 82.72 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 38.08 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 148.69 Bn
10 Genelux 88.08 Mn 26.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 19.51 Mn
Sep 30, 2023 24.07 Mn
Dec 31, 2022 -19.28 Mn
API Access

Genelux Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=GNLX&period=max&api_key=YOUR_API_KEY